Dermapharm Holding SE successfully maintains growth trend as planned

Grünwald, 22. März 2023 - At its meeting today, the Board of Management of Dermapharm Holding SE resolved to propose to the Company's Annual General Meeting, which is exxpected to be held on 14 June 2023, the distribution of a dividend for the 2022 financiel year amounting to EUR 1.05 per no-par value share carrying dividend rights (previous year: EUR 2.17 per share).

Grünwald, 14 March 2023 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, today published its unaudited preliminary consolidated figures (IFRS) for financial year 2022. Despite the difficult macroeconomic environment, Dermapharm succeeded in maintaining its growth trajectory.

The Arkopharma acquisition closed today, Thursday, 5 January 2023. Arkopharma was founded in 1980 in Carros, a suburb of Nice, France, with a focus on phytotherapy.